Nihon Kohden (OTCMKTS:NHNKY) Sees Strong Trading Volume – Here’s Why

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) saw unusually-high trading volume on Monday . 22,371 shares changed hands during trading, a decline of 17% from the previous session’s volume of 26,951 shares.The stock last traded at $9.48 and had previously closed at $9.2850.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Nihon Kohden Stock Performance

The stock has a fifty day simple moving average of $8.98 and a two-hundred day simple moving average of $9.94. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of 16.10 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKY) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.10. The business had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%. Equities analysts expect that Nihon Kohden Corporation will post 0.6 earnings per share for the current fiscal year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.